Mycronic AB (publ) (STO:MYCR)
Sweden flag Sweden · Delayed Price · Currency is SEK
296.20
+3.20 (1.09%)
May 6, 2026, 4:00 PM CET
← View all transcripts

Earnings Call: Q4 2025

Feb 5, 2026

Sven Chetkovich
Director of Investor Relations, Mycronic

Hello, and, welcome to the presentation of Mycronic's Q4 report. My name is Sven Chetkovich. I'm the Director, Investor Relations at Mycronic. And with me today, I have Mycronic's CEO, Anders Lindqvist, and the CFO, Pierre Brorsson, who will be presenting today. And with that, I hand over to Anders. Please go ahead and present Mycronic's Q4 report.

Anders Lindqvist
CEO, Mycronic

Thank you very much, Sven. This is what we will talk about today. No change from before, so about the quarter, of course, go deeper within the different divisions. Pierre will talk more about the financials, a few words on sustainability, and we have a question and answer session at the end of the presentation. And as usual, there is a market update in the material that will be posted on our website, which we will not present, but it could be interesting reading. So, starting with a short summary of the last quarter of last year. So we had a decline of order intake with 19% to a level just below SEK 2 billion, which is a good level.

It's on our annual average, but compared to a very strong quarter in 2024, it was nevertheless a decline of 19%. Very much explained by the lower order intake in Pattern Generators. Also, worth to note is that currency makes a lot of impact on all the numbers here, and Pierre will talk a little bit more about that in the financial part. Also, sales were more or less flat compared to last year, around SEK 2 billion, and we had decline in 3 divisions, so Pattern Generators, PCB assembly solutions, and also in the High Volume division. Then we had a quite good growth in the Global Technologies division that almost fully compensated for that difference, so being flat in total compared to the year before.

EBIT also declined, SEK 342 million, which is a margin of 17%. Backlog, more or less flat, at SEK 4.7 billion, which is a good and healthy backlog, I would say. Also the board of directors will propose to make a dividend of 3.25 SEK per share, which is a little bit an increase from before, and no extra dividend, as we did in last year. We made a small acquisition after the end of the period, a company called ETZ. That's a supplier of critical components for our PCB test business line, so it will not have a large impact on the numbers, but it will really reinforce our quality of the supply chain, so quite an important acquisition for us.

Going into the different divisions, starting with pattern generators, we could see that the markets were stable, I mean, and even positive. The semiconductor photomask market has shown positive development. I think you can read it by also in the reports from peers, that it's mainly driven from applications related to AI. On the display photomask side market, we see that stable as usual, a little bit irregular, but stable nevertheless. And we saw a decrease then of order intake, down to SEK 545 million, and this has to be compared then to a super strong quarter in 2024. We had 5 machines on order, or we got orders for 5 machines, 1 display mask writer, Prexision 8 Evo, FPS 6100 Evo, and also 3 SLX mask writers for the semicon industry.

Sales down to SEK 577 million. We delivered 6 equipment, and this is 18% down. One display mask writer, Prexision Lite 8 Evo, and one FPS 6100, and four SLX, so quite similar to the order intake, actually, but it's not the same equipment. Gross margin 58%, which is good, stable around that level, and EBIT SEK 173 million. Backlog is a bit down to SEK 2.6 billion. So as we said, that the total company backlog was flat, and you can understand that the backlog has increased in the other divisions. So we have 18 systems in the backlog as per end of the year. And after the period this year, we also received orders for the Prexision 8 Evo and an MMX.

You can also see that in the headline, we talk about continued R&D investments, and we do increase R&D investments. We develop new products to offer more equipment to our current customer base, and that kind of equipment is in the inspection technology area. So we will launch at the end of this year a range of inspection machines for the semiconductor photomask market, which are ramping up right now both in R&D investments, but also we are preparing space for the production for that. So quite a big, quite a large product for us. On PCB assembly solutions, we have talked before about the difficult market, and this continues to be difficult, especially the European market.

We have seen positive trend in Asia, and also US, but Asia is not so large for us for the PCB assembly solution, so, and the US market has been stable, but the European market has continued to be very, very weak. Every second year, there's a large show in Munich called Productronica, where we and our peers in the business, normally introduce new products, and we had two large introductions there: Gen I, which is an AI-enabled, inspection machine, and microA41, which is a continuation of our pick and place series. Order intake down to SEK 362, which is 7%. Also, sales down 10% to SEK 438. Gross margin at 40%, okay, and EBIT down to SEK 60. Backlog, SEK 147, which is quite okay, but still a difficult market in this division.

On the high-volume side, also participated on the Productronica show. Very, the large part of our strategy in the high volume is to expand sales outside of China, so very important to be present at those shows outside of China. We have also decided to put the listing. Some years ago, we announced that we are contemplating investigating the possibility to list Axxon on the China Stock Exchange, and this is put on hold right now. That listing would have contained also an investment program for employees. So, as that is not happening, we have launched what is called an ESOP program, which is Employee Share Ownership Participation program. So that is, which we just launched.

We also opened a new facility for production in Thailand to be able to supply machines not made in China, which is, to be more flexible in this, restricted world, that we live in today, from place of origin of, manufacturing. Order intake was down 30% to SEK 271 million. Sales was very strong at SEK 448 million, still a little bit less than the year before. Gross margin, 41%. A very good margin, and EBIT, SEK 55 million. And in this fifty-five, there is a bit of plus and minuses. We have a cost of this, share ownership program of SEK -23 million, and then we had a positive impact of, provisions for, personnel that was made, that contributed with SEK 13 million. Backlog, SEK 683 million, which is quite good or normal, I would say.

So all good there. Global Technologies, here we see a very strong development, as many companies now in these days report that it's driven by AI-related applications, and we have the same. This is in particular notable for our PCB test and also the Die Bonding business line. So, And also we have some acquisitions, of course, supporting all that. So order intake up almost 70% to SEK 773 million, and sales up 41% to SEK 757 million. And you can see the, sales contribution from acquired businesses, which is HProRobot and Surfx, SEK 131 million, but still a very strong development there. Very solid gross margin at 45%, EBIT, SEK 118 million, and, some negative impact from the recently acquired businesses of -SEK 6 million, and a very strong backlog of almost SEK 1.3 billion.

So very good development in this division, and an EBIT margin of 21% in the quarter. And I said, before, we also acquired this very small company, ETZ, which will not really have a lot of impact on the numbers, but really will solidify our supply chain for the PCB test business line. So, all that, we, we believe that we will continue to grow the business. And, this year, we see that, well, an outlook now, with still almost 12 months to go, or at least 11, to reach SEK 8.25 billion in sales. All right, now I hand over to Pierre to talk more about finances.

Pierre Brorsson
CFO, Mycronic

Yes, good morning from my side as well, and we will do a little bit deeper review of the numbers. Starting with this graph displaying the quarterly numbers, and we reach just above SEK 2 billion in sales. And this is compared to last year, a small decline of 2%, but it's really a volume increase. It's both organic and inorganic growth, and 11% negative currency impact. And this currency impact is even bigger on the order side because there you also revalue the orders on hand, so a very significant impact of the currencies in the quarter and also throughout the year. The aftermarket revenue, we exceeded SEK 500 million, so we are approaching SEK 2 billion on an annual basis. This is a good number.

However, for the first time since 2021, we were not sequentially growing on the, towards the same quarter last year. So we were slightly below the good quarter of 2024, mainly related to that we, at that time, had some upgrades in the pattern generators division, which we could not fully compensate for this year. EBIT margin 17%, a solid number, a bit high on the OpEx side, but really according to the plans that we have made and how we want to develop the company going forward. If we look at it on an annual basis, we have we ended the year just below SEK 8 billion, with an EBIT margin of 24%, good level.

Aftermarket revenue, as I mentioned, we are approaching SEK 2 billion, which is then constituting 25% of the net sales and continuously growing this part, so we will see fluctuations on the equipment side. But the aftermarket revenue is important to continuously, gradually build and grow, which we are doing at this point in time. You go a little bit deeper into the costing details and the different parts of the income statement comparing quarter-over-quarter, and this may look at us as a less positive staircase, but it's really largely according to plan. We had a little bit lower sales in the Pattern Generators division as a share of the total in the quarter, and thereby we have a small negative gross margin effect.

On the R&D side, Anders alluded to that, that we are continuing to spend at high pace and in very relevant projects, particularly in the pattern generators, but we also have an organic increase of the R&D spend in the high-volume division. In that division, in the high-volume division, we are also expanding the footprint, particularly outside China, and this drives a bit the marketing and sales cost. Here we also have, when we compare the numbers versus the prior year, we also have the newly acquired entities adding to all the cost categories here, and also the acquisition-related costs, and in particular, the retention and mechanism for the Surfx acquisition that is running over six months, which will end now in the fourth quarter, which is affecting the numbers a bit.

About SEK 10 million net impact of the China ESOP versus the reprovision release, as well. If we look at the 2025 full year bridge, we can see that we have been growing throughout the year, despite the currency headwind that we have had, and in several of the divisions, we have also improved the gross margin, in particular in the Global Technologies division, which we are very happy about. We have decided to do investments on the R&D side and on the marketing and sales side, in order to set the company for the future and to create the organic growth that we want to have sustainably going forward. We have also a bit higher acquisition-related cost and transaction costs this year compared to the prior year.

And then this other column that you see there, we have the net, mainly the net effect of the effects, realized and unrealized exchange differences. Ending the year at a solid SEK 1,940, which is 24% in relation to sales. Division by division, if we cut it that way, we have said that we had a little bit lower sales and also lower margin and higher R&D in Pattern Generators, and this is really the main explanation for the relatively lower EBIT in the fourth quarter. We had last year record quarter in PCB Assembly solutions and in High Volume. We could not fully match that this year, but particularly for PCB Assembly solutions, we had the best quarter of the year in the fourth quarter.

It's normally that way, but I think it's also fair to say that it's not a bad level, it's good level. In High Volume, we had a little bit slower ending of a solid year, and it looks quite good going into 2026 as well from there. Global Technologies, really good, despite not getting contribution yet from the acquired entities, delivering 20% or about 20% EBIT margin in the quarter, taking us to a total of 17% or SEK 342 million in the quarter. Looking at the full year, we were slightly lower than last year in Pattern Generators, mainly related to the R&D investments.

The number for PCB assembly solution is, of course, a bit bigger in relation to the baseline, so we did not reach what we wanted to reach in a tough market where we had our largest markets, Europe, having a negative economy and the U.S. having a bit of a difficult investment climate with tariffs, as well as the headwind from currencies. High Volume and Global Technologies on track, and for Global Technologies, even exceeding the plans we made. And here you see on the group functions that we have. This is largely transaction-related costs that has increased over this period of time. Ending the year on, as we said, 24% or SEK 194.

Cash flow-wise, it's all natural in relation to the activities we have conducted and, and the situation on the P&L, plus the acquisitions and the dividends that has been paid out. Maybe noteworthy is that we have about SEK 200 million less good change of working capital, and this is largely that we have a lower order stock in the pattern generators, where we have a significant portion of advanced payments from customers. We have almost spent SEK 1 billion in the acquisitions we have done during the year. Still, at the position where we can be active in the M&A market and with SEK 2.3 billion net, sorry, with SEK 2.3 billion cash and additionally facilities in place of SEK 2 billion. And with that, I hand the word back to Anders.

Anders Lindqvist
CEO, Mycronic

... Yeah, coming up soon. Thank you, Pierre. And, let's continue. So, as usual, a few words on sustainability. First, I want to talk about diversity, where we make some nice progress, and especially on the share of women in the workforce, both in the workforce, as also in the different managerial roles. And we could see that very notable, the Pattern Generators division had a good rise in the female representation from 19% to 22%. And also that in our annual employee engagement survey, we could see that diversity inclusion is having now the highest rated topic of them all. So positive development on that.

On other parts of sustainability, we had training for sales representative in this, and also purchasing managers that participated in different seminars to strengthening the due diligence that we do in our supply chain. So with that, Sven, we move over to question and answers.

Sven Chetkovich
Director of Investor Relations, Mycronic

Thank you, Anders, and thank you, Pierre. As you say, Anders, now we are moving over to our Q&A session, and today we will start with Handelsbanken and Fredrik Lithell. Fredrik, please go ahead and ask your questions.

Fredrik Lithell
Senior Research Analyst, Handelsbanken

Thanks for taking my questions. I'm going to keep it to two questions now. Maybe we could get a little bit elaboration on the outlook, the $8.25 billion, Pierre, if what, what US dollars are based on, and if this includes or do not include Cowin in Korea, and at the same time, maybe an update on the Cowin acquisition. The second question is, you talk about the investments that you expand the organization, increasing your TAM. You now also elaborate on that you will launch machines towards the end of this year. Would be very interesting to hear you talk more about that, to the extent you can, of course, Anders. Always interested to hear about machines. Thank you.

Anders Lindqvist
CEO, Mycronic

Okay, if I start then with the, a bit the outlook. The outlook is based on all we know now, which means the current exchange rates, as they stand today. We also believe that we will have a small contribution from Cowin, which we believe will be closed towards the end of the first quarter. This will not have a dramatic impact on the sales for this year, but we do believe a limited contribution from Cowin. Mm-hmm. And, yeah, regarding the new, new products then. So this is super exciting, and as you understand, this is something we have been working on for a while. So, you have seen that we have increased R&D spend over the time.

We have also increased manufacturing availability by moving out a division in our main production facility to make space for this new equipment. So this is inspection equipment for photomask for semiconductor, and it can inspect the quality of a full mask and not only the pattern, but also defects from particles and contamination, and so on. We will come into an environment with competition from very capable partners here. It will be mainly companies like Lasertec and KLA. Size of the market we see is quite equal to SLX, actually. So the size of the market is the same, we believe, the available market for us, like SEK 1 billion.

We believe also that the price of the machine will be in a similar range, something between from $4-$10 million per equipment. We have, of course, an ambition to take a part of that share, but we do have very capable competitors here as well, as we have in the laser-based mask writers as well. So this is super exciting. Launch will be to the end of this year, and we believe that the first revenues will be visible first 2027, really, where you can start to count on that. But we will have this year a further increase of R&D spend, a little bit more than what we currently do and most likely peak out during this year.

It's a lot of cost and no, no revenue so far, but we believe very much in this.

Fredrik Lithell
Senior Research Analyst, Handelsbanken

Yeah, yeah, I mean, I'm intrigued by that you sort of explain it so explicitly already now, or, you know, 11 months before you will launch it, giving your competitors some time to think about it. Do you bring any new type of technology angle into this? Is it something you could talk about?

Anders Lindqvist
CEO, Mycronic

Yeah. Well, all of the players here have a little bit of differentiation between how they do and how they compare patterns. Either you compare it to other masks, or you compare it to the drawings and so on. So we believe that we will have a unique position. We will also have the benefit of also being able to sell the mask writers, and the combination of this is given an additional value, actually, and which the others don't have, where we can use data from both equipments to kind of optimize the whole solution there.

So, no, so of course, we believe that we have something better, but, exactly how and what, I think we will need to come back a little bit later in the year really on, on the features and benefits and all the nice stuff.

Fredrik Lithell
Senior Research Analyst, Handelsbanken

Mm-hmm. Exciting, and good luck with that. And, I'm done for now. Thank you.

Sven Chetkovich
Director of Investor Relations, Mycronic

Thank you, Fredrik. Now we move over to SEB and Ina Djupsund. Please go ahead.

Ina Djupsund
Equity Research Analyst, SEB

Yes, hi-

Sven Chetkovich
Director of Investor Relations, Mycronic

Ask your questions.

Ina Djupsund
Equity Research Analyst, SEB

Thanks for taking my question as well. I have a question on pricing. I kind of assume FX effects is where it is now. How important of a growth driver will price be, and is it any particular division where price plays a bigger role?

Anders Lindqvist
CEO, Mycronic

Price is, of course, very important in all divisions, and, I think everywhere we can offer quite a large degree of differentiation. We, we are able to keep the prices quite high. But we don't really see any change in price pressure or, or so. We see, of course, a little bit, an effect in the PCB Assembly Solutions divisions, where you have the tariffs adding cost for customers, which we not always can transfer fully to the customer for different reasons. And so there, there, can it be a small decline? But otherwise, we, we keep, we keep pricing on every area and, and even increase where we can. Maybe have seen that the demand for some products in Global Technologies are extremely high, and then that's, of course, an opportunity to be a little bit more stiff on the pricing, so.

Ina Djupsund
Equity Research Analyst, SEB

Mm-hmm. Then how is capacity utilization? If we look at next year, I think there's a little bit fewer deliveries for PG and H2. How do you kind of approach that?

Anders Lindqvist
CEO, Mycronic

Yes, and we can still feel a bit of that, I think. So we have been maybe producing more than we could in the past times. I think that is, it's good for the production facility. But we're also expanding production for the PG division, also to be able to not only actually for this inspection machine, but also for the other product lines, to make that more efficient. So I think we have sufficient capacity. We face a little bit on the PCB test in the Global Technologies, where we have an extremely high demand.

And last year, we built a new factory, inaugurated that in January last year, and we are already making the first extension of that to meet this increased demand, so to be able to supply. We delivered double as much equipment as we did two years ago, so high pressure on production there. And also then in High Volume, we expand by adding additional production site, as mentioned in Thailand now, so.

Ina Djupsund
Equity Research Analyst, SEB

Mm-hmm.

Anders Lindqvist
CEO, Mycronic

So, yeah.

Ina Djupsund
Equity Research Analyst, SEB

Within PG, do you think you can still take orders that can be delivered in 2026 as well?

Anders Lindqvist
CEO, Mycronic

It depends on configuration and model, but theoretically or practically as well.

On the semicon side, we could definitely get something towards the back end of the year. Yes.

Ina Djupsund
Equity Research Analyst, SEB

Mm-hmm. Okay, thank you. That was all for me.

Sven Chetkovich
Director of Investor Relations, Mycronic

Thank you, Ina. And now we move over to ABG Sundal Collier, and Henrik Hintze. Please go ahead and ask your questions, Henrik.

Henrik Hintze
Equity Research Analyst, ABG Sundal Collier

Thank you. So about the employee stock option program in, in Axxon, I was just wondering if you could give us a bit more detail on, on the reasoning behind that, and if it's a one-off thing here, or if you will keep offering programs like this over time after this one is, done?

Anders Lindqvist
CEO, Mycronic

I can start, and then you can add. Yes. So this is the first, and the IPO that we were investigating should have had an investment program built into it. So now the IPO is on hold. We still want to offer an investment program. And the reason for that is that China is extremely competitive when it comes to talents, both to retain and to attract, but also to engage and to drive performance. So we believe that this is a very good way to fulfill that, to really keep the engagement, the performance of people and attract the best talent and retain our good people. So that is the motivation. Behind that, this program is the first one, and it's large.

We will, like a normal company, launch this every two, every three years, something like that, in a sequence with a duration of similar time between three and five years. But a lot—the first one now is larger than the coming because of that we didn't have a program during this investigation period of the IPO. But it will have a bit of cost last year, this year, and next year as well. Like, Pierre can explain a little bit more on that side, but it will look... But first of all, it should have a large benefit also, of course, of driving value and driving engagement and performance in the business. And it is a co-ownership program, so the—and it's quite broad.

We have invited 120 people, so it's a broad program, and we have almost 100% participation, so there is a big willingness to do this. Most China companies either have this kind of program or ownership through the real shares on the stock market. We believe that it's very good to stay competitive in the talent market.

Henrik Hintze
Equity Research Analyst, ABG Sundal Collier

Okay. Thank you. Secondly, on Global Technologies, the margin here in the quarter was quite a bit stronger than at least I had expected. So I was just wondering if you could give us any more detail regarding how we should think about that and the margin going into 2026.

Anders Lindqvist
CEO, Mycronic

I think we have, we have two larger portions that we've been owning for some time within Global Technologies. Both are benefiting from AI-driven demand in-

... in the background, this trickles down to us who do equipment for various parts of this chain. With this demand, we have seen good increases in sales, and we've also been able to improve the margins in this existing business. And then we have added acquired businesses which are profitably sound as the standalone entities. We have been suffering a little bit this year because we've had extraordinary acquisition-related costs. But we see good growth prospects and solid profitability in line with the group targets of the 20% that we see for Global Technologies specifically. I think it's perfectly realistic to believe.

Henrik Hintze
Equity Research Analyst, ABG Sundal Collier

Okay. Thank you. That's all for me.

Sven Chetkovich
Director of Investor Relations, Mycronic

Thank you, Henrik. Now over to Nordea and Anders Åkerblom.

Anders Åkerblom
Equity Research Analyst, Nordea

Thank you, Sven. Good morning. So firstly, I was wondering a bit on display. We saw recently in Samsung's Q4 report that they were discussing, you know, the recent memory price surge is impacting display shipments. What's your view on this?

Anders Lindqvist
CEO, Mycronic

So our view is, I mean, the link between photomask and price and so on display is quite far, I would say. So we haven't seen any change in the willingness to invest in photomask. We still have the growth drivers on the display side, with it being the area driven by new applications, mainly. We have also the layer and the complexity of the displays driven by new applications as well as new technology such as OLED and so on. So I think those the price changes and the supply and demand of memory and other components is more a short has a more short-term impact on the end customer business, I would say.

From our side, we don't see any change, and we haven't seen any change in demand either.

Anders Åkerblom
Equity Research Analyst, Nordea

Right. Thank you. I guess I was hinting a bit towards, in your customer discussions, do you think that that might drive a mix accretion towards, you know, a higher proportion of OLED compared to LCD, so that OEMs can maybe absorb that cost inflation to a greater extent?

Anders Lindqvist
CEO, Mycronic

Yeah, I think it's typical in the display industry that when demand is lower, they need to invest in technology to create demand and create technology and launch new features and so on. And I think that is still valid. But we also see quite a lot of new... this mix of technologies where you have OLED, you have micro LED, you have other types, you have the transparent displays, curved foldable phones, all that requiring more advanced production methods of displays, and in most cases, more layers that needs photo masks to be produced, so.

Anders Åkerblom
Equity Research Analyst, Nordea

Yep. Okay. Thank you, Anders. And, just a final question. I sense your wording in terms of the semi market outlook in PG is incrementally more positive compared to Q3. I mean, we've seen some developments during the quarter with, you know, TSMC and others raising targets, but kind of what underpins this more specifically?

Anders Lindqvist
CEO, Mycronic

I think you can see in different reports also that the semicon industry is forecast to start grow quite on a quite high level and very much driven to various type of AI. But also what we have seen in the past was China kind of standing out, being driving a lot of demand, and now we see a lot of demand created in other places, more kind of a more balanced approach. We can see that all those projects in the US are moving forward. We also see the European projects moving forward, also in Singapore, other places. India is gearing up and want to have their own capability domestic for semiconductor and so on.

So I think, yeah, all that together, I think, shows that the semicon market will be good, and at some point in time, that should be good for us as well, so.

Anders Åkerblom
Equity Research Analyst, Nordea

Very, very helpful. Thank you. Thank you, Anders. I'll leave it back to the others. Thank you.

Sven Chetkovich
Director of Investor Relations, Mycronic

Thank you, Anders. And now we go from Stockholm to London, and, Oliver Wong at Bank of America.

Oliver Wong
Associate, Bank of America

Hey, guys. Thanks for letting me ask the question. First question is on the semi mask writers. Just curious about what you guys are seeing in terms of demand from China, in terms of demand from the non-Chinese companies that, you know, may or may not be replacing- either replacing their old machines or not doing anything, or kind of, you know, upgrading with their existing machines from the incumbent supplier. Yeah, just kinda curious what you're seeing there relative to maybe this time last year.

Anders Lindqvist
CEO, Mycronic

Mm-hmm. Yeah, so China is different. So we saw at this time last year, we had a very strong and also had before that, a quite, quite big demand from China, from domestic mask manufacturers, which is less now. We still have demand from China, so I think it has more maybe normalized. It was maybe more than normal in the past time. But we do see at the same time, a pickup from the, from the other people, where everyone wants to position themself very good. China, and, and China still should be, have a huge potential for, for mask writers because the domestic, mask production in China compared to what is, what is used, it's still quite low.

So there's if China would go for 100%, in China for China, production on, on mask, that will require a lot more machines than what they already have, and that's maybe a theoretical thinking, but anyway, you can see that the potential is, is still there. Otherwise, we see potential. Everyone wants to make more, more capable masks and, and so on, also in, in more places. So we have we could see all the new factories building up, and the mask production facilities, is most likely to happen in the, in the neighborhood of those. So, so that, that compensates-

Oliver Wong
Associate, Bank of America

Okay

Anders Lindqvist
CEO, Mycronic

... compensates for the peak in China that we had, hopefully.

Oliver Wong
Associate, Bank of America

Okay. Got it. So it sounds like it's kind of more, you know, new fabs where they're kind of buying new equipment and they're going with you, versus, you know, kind of existing fabs where they're replacing old machines?

Anders Lindqvist
CEO, Mycronic

Yeah, I think that will be a mix, because I think existing fabs will also be upgraded, both capacity and capability. So, that's going on, and we're seeing that, so that's

Oliver Wong
Associate, Bank of America

absolutely.

Got it. Yeah, got it. And then in terms of margins for next year, I was wondering if you could just talk through kind of the big moving parts, yeah, just to give us a sense of how to expect, you know, margins to trend next year.

Pierre Brorsson
CFO, Mycronic

We typically don't really guide on margins. What we have issued is that we expect everything we own to be double-digit EBIT margin. This is base expectation on all divisions we have and all the business lines that we have. As a group, we should be consistently above 20%, which we have been now for some time. On the pattern generators, I think you can make the estimates by looking at the backlog and the aftermarket. Here we will continue to invest in R&D, slightly above the level we have done this year.

So, I think that gives you a little bit of guidance on where we will end up.

Oliver Wong
Associate, Bank of America

Okay, got it. Thank you.

Sven Chetkovich
Director of Investor Relations, Mycronic

Thank you, Oliver. And now we go back to Fredrik Lithell at Handelsbanken, to see if you have any further question.

Fredrik Lithell
Senior Research Analyst, Handelsbanken

Thank you very much. Pierre, in your prepared remarks, you talked about the after-market revenue and elaborated a little bit on that. You said you had a few more upgrades in 2024, for example, than you did have towards the end of this year. Can you, can you put some more color on this? Can you sort of give us a range of, of what value we talk about and how much it came down? Is it software, or is it... What, what's, what's in that, would be interesting.

Pierre Brorsson
CFO, Mycronic

It's software upgrades, and it can be laser upgrades as well, in that. As you see, we were a notch below the same quarter last year, so still had to explain why we, for the first time in five years, could not continue to grow, really. It's not a game-changing amount that differs on this.

Fredrik Lithell
Senior Research Analyst, Handelsbanken

Okay, that's perfect. Another question is, I mean, you have a quite distinct FX headwinds right now, and your position on the precision side, being the only vendor, do you update your price plans every year, or do you intend to update your prices and compensate for FX?

Pierre Brorsson
CFO, Mycronic

Basically, the pricing for the precision is, it's a dollar market. It's a dollar, dollar, baseline. Of course, when we deliver a new machine, new features, that comes in at a different level, it's very hard to say, "Okay, now the dollar went down 20%. We need to increase the price in dollars with 20%." That would distort the competitive landscape, among-

Fredrik Lithell
Senior Research Analyst, Handelsbanken

Mm

Pierre Brorsson
CFO, Mycronic

... our customers, given our strong position, so.

Fredrik Lithell
Senior Research Analyst, Handelsbanken

Mm. Okay. Thank you.

Sven Chetkovich
Director of Investor Relations, Mycronic

Thank you, Fredrik. And now we go to SEB and Ina Jupskås, to see if you have any further questions.

Ina Djupsund
Equity Research Analyst, SEB

I have one kind of high-level question. So, which division do you expect to contribute most to growth in 2026, and where do you see kind of tough comparison going into next year?

Anders Lindqvist
CEO, Mycronic

I think in general, I think we are. You have seen the development in Global Technologies, and I think there's. You can see also the backlog and the order intake in relation to the sales. So it's quite natural to believe that this will continue to contribute. And as Pierre said, the margins are also good in this division now, so that will be a good contribution. I think we will still have headwind on the market for PCB assembly systems for a while. That's even though the show in Munich last year had generated a lot of leads, but there's also a lot of hope in the market. So I think this is still. This will still be a struggle a little bit for us. Do you want to comment more on that one?

Pierre Brorsson
CFO, Mycronic

I think we see we do expect also High Volume to perform very well. Going into, we see very high interest from various markets in the products, and we start to get some maturity also outside China in what we do. So, I think those two divisions are probably the main growth engines for this year.

Anders Lindqvist
CEO, Mycronic

Mm-hmm. Yeah. And on the pattern generator, you can see we have the backlog described, and that's going normally according to plan. We have had the changes in deliveries, but they have all been driven by customer demands a little bit, but no, no significant difference and nothing that is moving out of the year. And as Pierre said, this will be a year of investing really in the final part of this new product program that we are launching.

And there you see, we will start the year strong. You see the deliveries in the first half of the year. So it will be a strong start, and should there be some semicon equipment coming in towards the back end, that will also be supportive to pattern generators.

Ina Djupsund
Equity Research Analyst, SEB

Super. Thank you for this.

Sven Chetkovich
Director of Investor Relations, Mycronic

Thank you, Ina. Now we move over to ABG Sundal Collier, and, Henrik, do you have any further questions, Henrik?

Henrik Hintze
Equity Research Analyst, ABG Sundal Collier

No, I think all my questions have been answered. Thank you.

Sven Chetkovich
Director of Investor Relations, Mycronic

Great. So then we move over to Anders Åkerblom at Nordea to see if you have any further questions.

Anders Åkerblom
Equity Research Analyst, Nordea

I always do. Just a final one on Global Technologies. I mean, we've adjusted for acquisition-related costs. You know, you've performed in the two most recent quarters at, you know, a 30% margin level. And I know you don't like to guide on margins. I don't mean to put you on the spot, but you're saying, you know, that all divisions you want to have, you know, above 20% margin. I don't think one should interpret that as you expecting margins to trend down in GT from, you know, the current level into next year, particularly with, you know, the accretive contribution from Surfx. Is that a correct assessment?

Pierre Brorsson
CFO, Mycronic

Yes. I think you can look at the past quarters and take out the acquisition-related cost and look in-

... into the future.

Anders Lindqvist
CEO, Mycronic

Yeah. There was nothing in-

Anders Åkerblom
Equity Research Analyst, Nordea

Very good

Anders Lindqvist
CEO, Mycronic

... there was nothing in the last two quarters that contributed more positively than expected, so it kind of was normal, I would say.

Anders Åkerblom
Equity Research Analyst, Nordea

Very good. That's, that's what I wanted to hear. Thank you.

Sven Chetkovich
Director of Investor Relations, Mycronic

Thank you, Anders. And now back to London again, and Oliver Wong, Bank of America, do you have any further questions?

Oliver Wong
Associate, Bank of America

Yeah, maybe just a question on the new inspection tools. You shared a TAM projection. That's helpful. Maybe like, you know, roughly, if you could give us a sense of what kind of market share do you think would be, you know, a good sort of achievable target for next year and kind of, you know, in the years to come?

Anders Lindqvist
CEO, Mycronic

I think it's maybe a little bit early to talk. We'll come with a much more detailed information closer to the launch. So, I think we have that planned to the second half of this year. But we believe that this market looks very much similar to the SLX market for us, size and price and so on, market share. We do have very capable competitors here. And we do have some benefits. So, we don't really have a point of view that we can share right now on how much. But, of course, we spend a lot of money in doing this, so we expect a good return, of course.

Oliver Wong
Associate, Bank of America

Makes sense. Thank you.

Sven Chetkovich
Director of Investor Relations, Mycronic

Thank you, Oliver. Well, with that, we have reached the end of today's presentation of Mycronic's Q4 report. Thank you very much for watching.

Powered by